Replay part 1:
Development of ART:
Mono - Dual - HAART
Duration: 10 mn |
Replay part 2:
Two-drug regimens for first-line ART
Duration: 20 mn |
Replay part 3:
Additional data
Duration: 8 mn |
Replay part 4:
New 2 DR in early switch
Duration: 21 mn |
Replay part 5:
2DR in virologically-suppressed individuals
Duration: 21 mn |
Replay part 6:
Long Acting 2DR as maintenance
Duration: 25 mn |
You can now download the slidekit
PPTx - 928 Ko
This webinar was brought to you with the support of our institutional partner |
|
|